AzTrials
AzTrials

Ureteral ObstructionNCT02419339

Early Infancy Ureteral Reimplantation for Distal Ureteral Obstruction

An observational study of Ureteral Obstruction and Urinary Diversion, run by University of Nebraska at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Prospective multicenter observational study of early infancy ureteral reimplantation for distal ureteral obstruction. The study is an observation study since the investigators will not assign specific interventions to the subjects of the study. Read more about this study

Who is it for?
Ages Up to 6 months
Conditions the study is for
Ureteral Obstruction, Urinary Diversion
What is being tested?
Extravesical ureteral reimplantation
Type of treatment
Surgery or procedure
How many people
5 participants
Where
1 siteUnited States
Study dates
22 May 2015to 4 Jun 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 6 months
  • All sexes
  • No healthy volunteers
  • Child

Study population: Infants (under 6 months of age) undergoing an extravesical ureteral reimplant for primary obstructed megaureter or ectopic ureter.

Who may be able to join

  • Children younger 6 months of age who have been recommended by their urologist to have a unilateral ureteral reimplant.
  • Unilateral obstructive disease (as defined by the BAPU)
  • Ipsilateral Single system
  • Ipsilateral VUR is ok
  • Contralateral reflux grades 1-3 ok as long as the reflux will be observed

Who cannot join

  • Duplicated systems
  • First Febrile UTI's and megaureter or ectopic ureter but no evidence of obstruction or loss of function
  • Neurogenic bladder, valves
  • Contralateral reflux grade 4-5

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Children's Hospital and Medical Center

    Omaha, Nebraska, 68114

Other trials in United States

About this study

Official title: Prospective Multicenter Observational Study of Early Infancy Ureteral Reimplantation for Distal Ureteral Obstruction

Prospective multicenter observational study of early infancy ureteral reimplantation for distal ureteral obstruction.

The study is an observation study since the investigators will not assign specific interventions to the subjects of the study.

The purpose of the study is to describe the surgical outcomes of early infancy ureteral reimplantation. Infants under 6 months of age with unilateral obstructed distal ureter, no other urologic pathologic and a normal contralateral kidney who have been recommended a ureteral reimplant by their pediatric urologist are eligible for the study. Patients that consent for the study will be prospectively followed for 1 year to record the outcomes of the surgery.

Read the detailed description

Initial evaluation and determining if surgery is indicated:

Prenatal diagnosis: patient will get renal ultrasound at 2-7 days of birth and will be started on prophylaxis with amoxicillin or Keflex. At 6 weeks a VCUG, renal ultrasound and mag 3 will be done per local protocols.

Patients considered for reimplant will have:

  1. SFU grade 3 and 4 hydroureteronephrosis
  2. Normal contralateral kidney (VUR grade 1-3 ok) as defined above plus
  3. Obstruction As defined by the BAPU (British Association of Paediatric Urologists consensus statement on the management of the primary obstructive megaureter)

If the patient meets criteria they will be consented for this observational study (before the surgery) and will have an extravesical ureteral reimplant in the next 0-2 months.

After the patient has been consented to participate in the study and before surgery, the investigators need to notify the main study site (Omaha) about the new patient and information will be recorded at the main site about the patient without patient identifiers. This is done so that they study can be analyze as an intention to treat.

Please note that this is an observational study: patients will have the same interventions and diagnostic tests regardless whether they chose or not to participate in the study. The investigator does not assign specific interventions to the subjects of the study. The protocol is only a suggested guideline to standardize details of the surgery and follow up of the patients among the different centers.

Postnatal diagnosis: patients with no history of prenatal hydronephrosis presenting with febrile UTI. If under 6 weeks of age they will be placed on prophylaxis with amoxicillin or Keflex. At 6 weeks a VCUG, renal ULTRASOUND and mag 3 will be done per local protocols. If presenting in between 6 weeks and 6 months of life they will undergo VCUG and Mag 3 after completing antibiotics course (7-10 days). Patients with febrile UTI not responding to antibiotics can be diverted with a percutaneous nephrostomy and once stable undergo testing.

Patients considered for reimplant will have:

  1. SFU grade 3 and 4 hydroureteronephrosis
  2. Normal contralateral kidney as defined above plus
  3. Obstruction As defined by the BAPU If the patient fulfills criteria and the reimplant can be scheduled before age 7 months, they will be consented for the study.

After the patient has been consented to participate in the study and before surgery, the investigators need to notify the main study site (Omaha) about the new patient and information will be recorded at the main site about the patient without patient identifiers. This is done so that they study can be analyze as an intention to treat.

Patients initially not meeting criteria for surgery who had breakthrough UTI's Patients with unilateral megaureter but either no obstruction as defined above or no differential function loss can be considered for the study if they have Breakthrough UTI's while on prophylaxis and the surgery will be done at less than 7 months of age.

Follow up If patient does not meet criteria for surgery, follow up will be done as per local protocols with renal US +/- Mag 3 renal scans.

Follow up US can be done every 6-12 weeks. If US shows worsening patient can proceed with surgery or a Mag 3 can be done alternatively and any worsening >5% DFx on the mag 3 can could indicate surgery.

Below is a summary of patients eligible for surgery (all surgeries will have to be done under 7 months of age to enter into the study as well as inclusion and exclusion criteria must be followed):

  1. Prenatally diagnosed unilateral distal obstruction that at 6 weeks have less than 40% DFx and SFU 3 or 4 hydronephrosis.
  2. Patients who present postnatally with a febrile UTI and unilateral distal ureteral obstruction and on evaluation are found to have less than 40% DFx, and SFU 3 or 4 hydronephrosis.
  3. Prenatally or postnatally diagnosed patients with distal obstruction who on initial evaluation did not meet criteria, but then subsequently had a Breakthrough febrile UTI's while on abx prophylaxis.
  4. Prenatally or postnatally diagnosed patients with distal obstruction who on initial evaluation did not meet criteria, but on follow up US showed worsening hydronephrosis. Alternatively for these patients a Mag 3 can be repeated with surgery done for worsening parameters on the mag 3 (loss of more than 5% of function) .

Operative considerations Pfannenstiel incision. Fascial incision can be vertical or horizontal. Ureter dissected and divided at the bladder with 4-0 polydioxanone (suture ligation) if megaureter or as distal as possible/safe for ectopic ureter. Distal narrow or diseased looking segment excised.

Using 4 4-0 silk stay sutures, the borders or the detrusorrhaphy will be marked posterior laterally. A 3 cm detrusorrhaphy (minimum) down to mucosa will be done next.

Tapering (optional). Ureters more than 8-10 mm in diameter could be tapered. Based on some computer models research done by us, would recommend tapering just the distal ureter down to 4-5 mm in diameter over a stent left for 6 weeks. Ureter should not be tapered for more than a few centimeters in length to avoid devascularization. Alternatively, tapering can be left to the discretion of the surgeon.

The ureter will be anastomosed with running 5-0 or 6-0 polyglactin to the distal detrusorrhaphy making only a small mucosal opening.

A distal advancement suture will be placed to secure the UO distally in the bladder.

The detrusor will be then closed with interrupted 3-0 polyglactin stitches making sure no to obstruct the ureter proximal at the hiatus.

For non tapered reimplants, a stent will be sutured to the foley and removed in 5-7 days.

Drain at the discretion of the surgeon (preferably no drain) Foley will be left for 5-7 days in everyone. Overnight observation for all patients with extended hospital stay as needed for complications.

Follow up Antibiotic prophylaxis until first VCUG. (sulfamethoxazole/trimethoprim 3-4 mg/kg/day) 3 months: renal US, and VCUG. Mag 3 only for cases where the renal US showed no improvement (renal US stable or worse). Mag 3 can be done per the discretion of the surgeon too.

Continue antibiotic prophylaxis for girls and uncircumcised boys with VUR. May stop antibiotic prophylaxis for circumcised boy with VUR.

1 year: renal US, and VCUG (if previous VCUG showed VUR). Mag 3 only for cases where the renal US showed no improvement (renal US stable or worse). Mag 3 can be done per the discretion of the surgeon too.

Recurrent Febrile UTI's: will document any febrile UTI's defined at temp more than 38.5 with urine analysis with >10 white blood cells per high power field on microscopic exam and a positive urine culture more than 1 months after removal of foley or stent. Febrile UTI's within a month of the removal of foley or stent will be considered operative complications.

Being tested
Extravesical ureteral reimplantation
Medical subject headings
Ureteral Obstruction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Extravesical ureteral reimplantationProcedure or surgery

    Extravesical ureteral reimplantation with or without tapering

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Reoperation

    Need for reoperation either for persistent documented obstruction or reflux with recurrent febrile UTI's

    Measured: 1 year

Secondary outcomes (1)
  1. Recurrent Febrile UTI's

    Recurrent febrile urinary tract infections defined as fever more than 38.5, positive urine culture with more than 100,000 organism from a cath specimen and urine analysis with more than 10 leukocytes per high power field.

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Apr 2015 (estimated)
  2. Study start22 May 2015
  3. Primary completion4 Jun 2019
  4. Study completion4 Jun 2019

Why it stopped: Principal investigator is moving to a different institution.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
5 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02419339
Sponsor's protocol ID
0368-15-EP
Status last verified
Oct 2023
First submitted
8 Apr 2015
Last updated
6 Oct 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • de Jong TP, Dik P, Klijn AJ, Uiterwaal CS, van Gool JD. Ectopic ureterocele: results of open surgical therapy in 40 patients. J Urol. 2000 Dec;164(6):2040-3; discussion 2043-4.

    PubMed 11061921
  • de Kort LM, Klijn AJ, Uiterwaal CS, de Jong TP. Ureteral reimplantation in infants and children: effect on bladder function. J Urol. 2002 Jan;167(1):285-7. doi: 10.1097/00005392-200201000-00084.

    PubMed 11743341
  • Gearhart JP. Primary obstructive ureter in neonates. Treatment by temporary uretero-cutaneostomy. Br J Urol. 1994 Jul;74(1):133-4. No abstract available.

    PubMed 8044519
  • Greenfield SP, Griswold JJ, Wan J. Ureteral reimplantation in infants. J Urol. 1993 Nov;150(5 Pt 1):1460-2. doi: 10.1016/s0022-5347(17)35809-3.

    PubMed 8411425
  • Kaefer M, Misseri R, Frank E, Rhee A, Lee SD. Refluxing ureteral reimplantation: a logical method for managing neonatal UVJ obstruction. J Pediatr Urol. 2014 Oct;10(5):824-30. doi: 10.1016/j.jpurol.2014.01.027. Epub 2014 Feb 28.

    PubMed 24850437
  • Kitchens DM, DeFoor W, Minevich E, Reddy P, Polsky E, McGregor A, Sheldon C. End cutaneous ureterostomy for the management of severe hydronephrosis. J Urol. 2007 Apr;177(4):1501-4. doi: 10.1016/j.juro.2006.11.076.

    PubMed 17382764
  • Kogan BA, Gohary MA. Cutaneous ureterostomy as a permanent external urinary diversion in children. J Urol. 1984 Oct;132(4):729-31. doi: 10.1016/s0022-5347(17)49844-2.

    PubMed 6471219
  • Lee SD, Akbal C, Kaefer M. Refluxing ureteral reimplant as temporary treatment of obstructive megaureter in neonate and infant. J Urol. 2005 Apr;173(4):1357-60; discussion 1360. doi: 10.1097/01.ju.0000152317.72166.df.

    PubMed 15758801
  • Liu C, Chin T, Wei C. Surgical treatment of vesicoureteral reflux in infants under 3 months of age. J Pediatr Surg. 1998 Nov;33(11):1716-9. doi: 10.1016/s0022-3468(98)90617-0.

    PubMed 9856903
  • MacGregor PS, Kay R, Straffon RA. Cutaneous ureterostomy in children--long-term followup. J Urol. 1985 Sep;134(3):518-20. doi: 10.1016/s0022-5347(17)47271-5.

    PubMed 4032552
  • Peters CA, Mandell J, Lebowitz RL, Colodny AH, Bauer SB, Hendren WH, Retik AB. Congenital obstructed megaureters in early infancy: diagnosis and treatment. J Urol. 1989 Aug;142(2 Pt 2):641-5; discussion 667-8. doi: 10.1016/s0022-5347(17)38842-0.

    PubMed 2746792
  • Sarduy GS, Crooks KK, Smith JP, Wise HA 2nd. Results in children managed by cutaneous ureterostomy. Urology. 1982 May;19(5):486-8. doi: 10.1016/0090-4295(82)90604-5.

    PubMed 7080321
  • Farrugia MK, Hitchcock R, Radford A, Burki T, Robb A, Murphy F; British Association of Paediatric Urologists. British Association of Paediatric Urologists consensus statement on the management of the primary obstructive megaureter. J Pediatr Urol. 2014 Feb;10(1):26-33. doi: 10.1016/j.jpurol.2013.09.018. Epub 2013 Oct 16.

    PubMed 24206785

Questions about this trial

What is this clinical trial studying?

An observational study of Ureteral Obstruction and Urinary Diversion, run by University of Nebraska at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 6 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Principal investigator is moving to a different institution.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Reoperation (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02419339, which also lists 13 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in